PREDICTORS OF FATIGUE IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引：0
|
作者：
Freites Nunez, Dalifer [1 ,2 ]
Redondo, Marta [3 ]
Abasolo, Lydia [1 ,2 ]
Lois, Pia [1 ]
Hernandez, Isabel [1 ]
Vadillo, Cristina [1 ]
Leon, Leticia [2 ,3 ]
机构：
[1] Hosp Clin San Carlos, Rheumatol, Madrid, Spain
[2] Sanitaria Hosp Clin San Carlos IdISSC, Inst Invest, Rheumatol, Madrid, Spain
[3] Univ Camilo Jose Cala, Fac Educ & Salud, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.7177
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0246
引用
下载
收藏
页码：1579 / 1580
页数：2
相关论文
共 50 条
  • [41] Machine Learning Prediction of Treatment Response to Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Salehi, Fatemeh
    Lopera Gonzalez, Luis I.
    Bayat, Sara
    Kleyer, Arnd
    Zanca, Dario
    Brost, Alexander
    Schett, Georg
    Eskofier, Bjoern M.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [42] Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study
    Antonio Gomez-Centeno
    Esteban Rubio-Romero
    Juan Gabriel Ovalles
    Sara Manrique-Arija
    Sara Marsal-Barril
    Juan Amarelo-Ramos
    Javier del Pino-Montes
    Santiago Muñoz-Fernández
    Sagrario Bustabad
    Ceferino Barbazán-Álvarez
    Rheumatology International, 2019, 39 : 2015 - 2024
  • [43] Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
    Adami, Giovanni
    Fassio, Angelo
    Rossini, Maurizio
    Bertelle, Davide
    Pistillo, Francesca
    Benini, Camilla
    Viapiana, Ombretta
    Gatti, Davide
    RMD OPEN, 2023, 9 (01):
  • [44] Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Pawar, Ajinkya
    Desai, Rishi J.
    He, Mengdong
    Bessette, Lily
    Kim, Seoyoung C.
    ACR OPEN RHEUMATOLOGY, 2021, 3 (08) : 531 - 539
  • [45] Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs
    Singh, Namrata
    Gold, Laura S.
    Lee, Jiha
    Wysham, Katherine D.
    Andrews, James S.
    Makris, Una E.
    England, Bryant R.
    George, Michael D.
    Baker, Joshua F.
    Jarvik, Jeffrey
    Heagerty, Patrick J.
    Singh, Siddharth
    ARTHRITIS CARE & RESEARCH, 2024, 76 (05) : 627 - 635
  • [46] Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
    Osiri, Manathip
    Dilokthornsakul, Piyameth
    Chokboonpium, Sasitorn
    Suthipinijtham, Pichaya
    Koolvisoot, Ajchara
    ADVANCES IN THERAPY, 2021, 38 (09) : 4885 - 4899
  • [47] Healthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan
    Ikeda, Kei
    Kaneko, Yuko
    Tsujita, Yuki
    Kawaguchi, Isao
    Patel, Jayeshkumar
    Yamazaki, Toru
    Fang, Siran
    Kawahito, Yutaka
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 910 - 917
  • [48] Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
    Manathip Osiri
    Piyameth Dilokthornsakul
    Sasitorn Chokboonpium
    Pichaya Suthipinijtham
    Ajchara Koolvisoot
    Advances in Therapy, 2021, 38 : 4885 - 4899
  • [49] Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
    Fletcher, Ashley
    Lassere, Marissa
    March, Lyn
    Hill, Catherine
    Barrett, Claire
    Carroll, Graeme
    Buchbinder, Rachelle
    RHEUMATOLOGY, 2022, 61 (10) : 3939 - 3951
  • [50] PRICE TRENDS AND ANALYSIS OF TARGETED IMMUNOMODULATORY (TIM) DISEASE-MODIFYING ANTIRHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS THERAPY
    Adekunle, O.
    Wang, Y.
    Yunusa, I
    Fleming, M.
    Seoane-Vazquez, E.
    Brown, L. M.
    VALUE IN HEALTH, 2024, 27 (06) : S109 - S109
12345